The Biobased and Renewable Products Advocacy Group (BRAG) helps members develop and bring to market their innovative biobased and renewable chemical products through insightful policy and regulatory advocacy. BRAG is managed by B&C® Consortia Management, L.L.C., an affiliate of Bergeson & Campbell, P.C.

By Lynn L. Bergeson 

On August 17, 2020, the U.S. Environmental Protection Agency (EPA) announced that it is accepting nominations for the 2021 Green Chemistry Challenge Awards. EPA intends these awards to recognize innovation by American businesses and researchers that redesign chemical products and processes to reduce or eliminate the use and manufacture of hazardous substances. The 2021 Green Chemistry Challenge Awards nomination package is now available, and nominations are due December 4, 2020. EPA states that it anticipates giving awards to “outstanding green chemistry technologies” in five categories in June 2021. EPA will host a webinar on September 23, 2020, for those interested in applying. During the webinar, EPA will provide an overview of the requirements, criteria, and tips for submitting a nomination package.


 

By Lynn L. Bergeson and Ligia Duarte Botelho, M.A.

The University of Minnesota Extension (UME) recently published a report titled “Economic Contribution of the Biobased Industrial Products Industry in Minnesota: 2019.” The report accounts for the economic impacts from the Minnesota Bioincentive Program enacted in 2015. Some of the key findings outlined by UME include but are not limited to the ones outlined below:

  • In 2019, companies claiming the Minnesota Bioincentive received $1.5 million in incentives. For every tax dollar invested in incentives, $407.10 is generated in the economy. In addition, for every dollar of incentive, approximately $8.90 is collected in taxes.
  • Construction activities of Minnesota biobased industrial product companies generated an estimated $1.2 billion of economic activity in the state, including $540.6 million in labor income. These activities also supported employment for more than 8,000 workers and generated approximately $46.5 million in tax collections.
  • Operations of Minnesota’s biobased industrial product companies generated an estimated $610.7 million of economic activity resulting from their operations, including $127 million in labor income. It also supported employment for more than 2,000 workers in the state and generated an estimated $13.3 million in tax collections.

According to the report, these impacts are annual and will continue to grow as long as companies do. A full copy of the report is available here.


 

By Lynn L. Bergeson 

On July 13, 2020, DOE’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs Office (SBIR/STTR Programs Office) issued topics for its FY 2021 SBIR/STTS Phase I Release 1 Funding Opportunity Announcement (FOA). The topics are available online. DOE participating program offices include the Office of Science’s (SC) Office of Advanced Scientific Computing Research (ASCR), Office of Basic Energy Sciences (BES), Office of Biological and Environmental Research (BER), and Office of Nuclear Physics (NP). DOE SBIR/STTR will hold a webinar on August 14, 2020, to discuss the FOA and application process, as well as important changes to the SBIR and STTR programs for 2021. Important upcoming dates include:

  • August 31, 2020 – Letter of Intent (LOI) Due;
  • September 21, 2020 Non-responsive LOI Feedback Provided;
  • October 13, 2020 – Application Due;
  • January 4, 2021 – Award Notification; and
  • February 16, 2021 – Start of Grant Budget Period.

The 2021 important dates are subject to change.

Tags: DOE, SBIR, STTR

 

By Lynn L. Bergeson 

On July 14, 2020, DOE EERE announced that it will fund approximately $53 million to 49 new SBIR and STTR R&D projects. The selected projects will receive Phase II Release 2 grants for principal R&D efforts based on the technical feasibility demonstrated in Phase I projects. Phase II awards range up to $1,500,000 for two years. Further information about the awardees can be found here.


 

By Lynn L. Bergeson and Ligia Duarte Botelho, M.A.

On July 1, 2020, DOE’s EERE announced a request for proposals (RFP) for R&D projects that support DOE’s H2@Scale vision for large-scale, affordable hydrogen production, storage, distribution, and utilization across various sectors. H2@Scale is an initiative focused on exploring the potential for wide-scale hydrogen production and utilization in the United States to enable resilience and sustainability of the power generation and transmission sectors. The initiative’s goal is to align diverse multibillion-dollar domestic industries with domestic competitiveness and job creation. The RFP comes from the National Renewable Energy Laboratory (NREL) and DOE’s Hydrogen and Fuel Cell Technologies Office (HFTO). Two areas of R&D are of particular interest to NREL and HFTO:

  • Advancing hydrogen fuel technologies for medium- and heavy-duty fuel cell vehicles; and
  • Addressing technical barriers to hydrogen blending in natural gas.

HFTO will fund NREL services, staff time, and facilities necessary to support each selected project. Selected projects must include one or more National Laboratories and must include partners from one or more of the following: universities, industries, non-profits, associations, institutes, codes and standards organizations, or other relevant stakeholders. Proposals must be submitted on or prior to July 31, 2020, at 7:00 p.m. (EDT).


 

By Lynn L. Bergeson

On July 1, 2020, DOE’s EERE announced that the Oak Ridge National Laboratory (ORNL) issued a Notice of Opportunity (NOO) providing small businesses and other industry partners with more affordable access to ORNL’s Building Technologies Research and Integration Center (BTRIC). The NOO allows small businesses to undertake collaborative, short-term R&D projects that accelerate the development of new energy-efficient building technologies. Funded by DOE’s Building Technologies Office (BTO), selected participants will have access to ORNL’s experienced staff, equipment, and research capabilities. This NOO is particularly designed to significantly reduce the time, cost, and risk of bringing a novel product to market and to accelerate and streamline partnering processes. Each project cost share will be reduced from 50 percent to 20 percent to encourage innovation despite economic hardships caused by the COVID-19 pandemic.

ORNL is requesting proposals from industry to assess whether their technological approaches could contribute to BTO’s goal of 30 percent reduction in building energy usage by 2030 relative to the 2010 baseline. Technology areas of interest include:

  • Heating, ventilation, and air conditioning (HVAC), water heating, and appliances;
  • Windows and building envelope;
  • Solid-state lighting;
  • Building energy modeling;
  • Sensors and controls;
  • Grid-interactive efficient buildings; and
  • Residential and commercial building integration.
Tags: DOE, ORNL

 

By Lynn L. Bergeson

On June 26, 2020, the Biotechnology Innovation Organization (BIO), a Biobased and Renewable Products Advocacy Group (BRAG®) member, announced the winners of its 2020 Start-Up Stadium competition. The competition had 30 finalists that were evaluated during BIO Digital in June, by expert judges with backgrounds in investment, entrepreneurship, start-ups, economic development, capital formation, and academia. Five winners were chosen based on their commercially viable cutting-edge technologies and therapeutic solutions. Competition winners will receive:

  • A one-year membership in BIO;
  • Four hours of complimentary legal services;
  • One-hour advisory discussion with two venture capital firms; and
  • A “fast-track” accelerator application and nomination into the final selection phase for up to a $10,000 sequencing grant.

 

By Lynn L. Bergeson and Ligia Duarte Botelho, M.A.

In March 2020, a paper by master’s degree student Anastasia Prosina titled “Algae-Based Printer Ink as the Way to Foster In-Situ Resource Utilization in Habitation Structures” was published in ResearchGate. Prosina’s paper, submitted to Sasakawa International Center for Space Architecture (SICSA), proposes that the most feasible long-term habitat off-Earth will consist of a 3D printed mixture of algae and regolith, the layer of unconsolidated rocky material covering bedrock. Proposed as an alternative to building structures in space that require intensive mining and sifting, the 3D printed mixture can be cultivated in a lab controlled by biological media. In addition, “[t]he utilization of algae off-Earth is not limited to a singular application and its cultivation would allow for a substantial yield of products, and local micro and macro environmental benefits.” According to Prosina, because of the high protein in and natural thermostatic qualities of algae biomass, this new printing mixture would allow for easier and safer production of everyday consumables, including clothes. Prosina’s paper outlines the benefits and complications of algae production and utilization processes, concluding that algae has the best potential for establishing long-term habitation on the Moon and Mars.


 

Register now for the American Bar Association (ABA) webinar “Navigating the Jurisdictional Tightrope Between Biopesticides, Biostimulants, and Related Emerging Technologies” with Bergeson & Campbell P.C. (B&C®) professionals deconstructing the jurisdictional boundaries distinguishing pesticides, biopesticides, plant regulators, biostimulants, and related technologies. The webinar will focus on draft EPA guidance intended to clarify the lines between and among those products that are subject to FIFRA registration as plant regulators and those biostimulant products not subject to FIFRA registration. The webinar also will focus on new and evolving chemistry and technology issues that may blur some jurisdictional lines or potentially move products from one category to another.  Lynn L. Bergeson, Managing Partner, B&C; Lisa R. Burchi, Of Counsel, B&C; and Sheryl Dolan, Senior Regulatory Consultant, B&C, will present.


 

By Lynn L. Bergeson and Ligia Duarte Botelho, M.A.

On April 6, 2020, the U.S. Food and Drug Administration (FDA) published a report that provides options and recommendations for a new methodology to evaluate changes in resource capacity needs of human drug and biosimilar biologic review programs. Titled “Independent Evaluation of the PDUFA and BsUFA Resource Capacity Planning Adjustment Methodology: Evaluation and Recommendations,” the analysis of the methodology was reviewed by an outside consultant, contracted by FDA. The report summarizes the evaluation of FDA’s proposed capacity planning adjustment methodology to calculate the annual fees for human drugs and biosimilar biologics under the FDA Reauthorization Act of 2017. According to the report’s executive summary, “[t]he report examines the options and recommendations for the proposed capacity adjustment methodology to accurately assess changes in the resource and capacity needs for prescription drug and biologic biosimilar fee direct review work.” Relevant to those interested in developing, and streamlining such products, as part of the Prescription Drug User Fee Amendments of 2017 (PDUFA VI) and Biosimilar User Fee Amendments of 2017 (BsUFA II) commitments, FDA is developing this methodology to improve its user fee resources. Comments will be accepted until May 6, 2020.

Tags: FDA, Biologic

 
 1 2 3 >  Last ›